- Home
- PETZ vs EVGN Comparison
PETZ vs EVGN Comparison
Compare PETZ & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- EVGN
- Stock Information
- Founded
- PETZ 2002
- EVGN 1999
- Country
- PETZ China
- EVGN Israel
- Employees
- PETZ N/A
- EVGN N/A
- Industry
- PETZ Steel/Iron Ore
- EVGN Agricultural Chemicals
- Sector
- PETZ Industrials
- EVGN Industrials
- Exchange
- PETZ Nasdaq
- EVGN Nasdaq
- Market Cap
- PETZ 10.9M
- EVGN 10.9M
- IPO Year
- PETZ 2017
- EVGN N/A
- Fundamental
- Price
- PETZ $1.03
- EVGN $1.28
- Analyst Decision
- PETZ
- EVGN Strong Buy
- Analyst Count
- PETZ 0
- EVGN 1
- Target Price
- PETZ N/A
- EVGN $3.50
- AVG Volume (30 Days)
- PETZ 8.1K
- EVGN 58.4K
- Earning Date
- PETZ 12-16-2025
- EVGN 11-20-2025
- Dividend Yield
- PETZ N/A
- EVGN N/A
- EPS Growth
- PETZ N/A
- EVGN N/A
- EPS
- PETZ 0.26
- EVGN N/A
- Revenue
- PETZ $563,726.00
- EVGN $9,444,000.00
- Revenue This Year
- PETZ N/A
- EVGN N/A
- Revenue Next Year
- PETZ N/A
- EVGN $12.35
- P/E Ratio
- PETZ $5.04
- EVGN N/A
- Revenue Growth
- PETZ 74664.72
- EVGN 42.25
- 52 Week Low
- PETZ $0.65
- EVGN $0.95
- 52 Week High
- PETZ $1.68
- EVGN $2.42
- Technical
- Relative Strength Index (RSI)
- PETZ 42.95
- EVGN 51.47
- Support Level
- PETZ $1.03
- EVGN $1.12
- Resistance Level
- PETZ $1.07
- EVGN $1.33
- Average True Range (ATR)
- PETZ 0.05
- EVGN 0.06
- MACD
- PETZ -0.00
- EVGN -0.00
- Stochastic Oscillator
- PETZ 0.00
- EVGN 61.90
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.